196 related articles for article (PubMed ID: 11840451)
1. Magnesium abnormalities of skeletal muscle in dermatomyositis and juvenile dermatomyositis.
Niermann KJ; Olsen NJ; Park JH
Arthritis Rheum; 2002 Feb; 46(2):475-88. PubMed ID: 11840451
[TBL] [Abstract][Full Text] [Related]
2. Muscle abnormalities in juvenile dermatomyositis patients: P-31 magnetic resonance spectroscopy studies.
Park JH; Niermann KJ; Ryder NM; Nelson AE; Das A; Lawton AR; Hernanz-Schulman M; Olsen NJ
Arthritis Rheum; 2000 Oct; 43(10):2359-67. PubMed ID: 11037897
[TBL] [Abstract][Full Text] [Related]
3. Analysis of 31P MR spectroscopy data using artificial neural networks for longitudinal evaluation of muscle diseases: dermatomyositis.
Park JH; Kari S; King LE; Olsen NJ
NMR Biomed; 1998; 11(4-5):245-56. PubMed ID: 9719579
[TBL] [Abstract][Full Text] [Related]
4. Reduced oxidative phosphorylation and proton efflux suggest reduced capillary blood supply in skeletal muscle of patients with dermatomyositis and polymyositis: a quantitative 31P-magnetic resonance spectroscopy and MRI study.
Cea G; Bendahan D; Manners D; Hilton-Jones D; Lodi R; Styles P; Taylor DJ
Brain; 2002 Jul; 125(Pt 7):1635-45. PubMed ID: 12077012
[TBL] [Abstract][Full Text] [Related]
5. Use of magnetic resonance imaging and P-31 magnetic resonance spectroscopy to detect and quantify muscle dysfunction in the amyopathic and myopathic variants of dermatomyositis.
Park JH; Olsen NJ; King L; Vital T; Buse R; Kari S; Hernanz-Schulman M; Price RR
Arthritis Rheum; 1995 Jan; 38(1):68-77. PubMed ID: 7818575
[TBL] [Abstract][Full Text] [Related]
6. Near-infrared spectroscopy during exercise and recovery in children with juvenile dermatomyositis.
Habers GE; De Knikker R; Van Brussel M; Hulzebos E; Stegeman DF; Van Royen A; Takken T
Muscle Nerve; 2013 Jan; 47(1):108-15. PubMed ID: 23042630
[TBL] [Abstract][Full Text] [Related]
7. MHC class I and II expression in juvenile dermatomyositis skeletal muscle.
Sallum AM; Kiss MH; Silva CA; Wakamatsu A; Sachetti S; Lotufo S; Matsumura N; Marie SK
Clin Exp Rheumatol; 2009; 27(3):519-26. PubMed ID: 19604449
[TBL] [Abstract][Full Text] [Related]
8. The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patients.
Giancane G; Lavarello C; Pistorio A; Oliveira SK; Zulian F; Cuttica R; Fischbach M; Magnusson B; Pastore S; Marini R; Martino S; Pagnier A; Soler C; Staņēvicha V; Ten Cate R; Uziel Y; Vojinovic J; Fueri E; Ravelli A; Martini A; Ruperto N;
Pediatr Rheumatol Online J; 2019 May; 17(1):24. PubMed ID: 31118099
[TBL] [Abstract][Full Text] [Related]
9. Metabolic disturbances during short exercises in dermatomyositis revealed by real-time functional 31P magnetic resonance spectroscopy.
Pfleiderer B; Lange J; Loske KD; Sunderkötter C
Rheumatology (Oxford); 2004 Jun; 43(6):696-703. PubMed ID: 15054156
[TBL] [Abstract][Full Text] [Related]
10. P-31 magnetic resonance spectroscopy in polymyositis and dermatomyositis. Altered energy utilization during exercise.
Newman ED; Kurland RJ
Arthritis Rheum; 1992 Feb; 35(2):199-203. PubMed ID: 1734909
[TBL] [Abstract][Full Text] [Related]
11. Myogenic Progenitor Cells Exhibit Type I Interferon-Driven Proangiogenic Properties and Molecular Signature During Juvenile Dermatomyositis.
Gitiaux C; Latroche C; Weiss-Gayet M; Rodero MP; Duffy D; Bader-Meunier B; Glorion C; Nusbaum P; Bodemer C; Mouchiroud G; Chelly J; Germain S; Desguerre I; Chazaud B
Arthritis Rheumatol; 2018 Jan; 70(1):134-145. PubMed ID: 28941175
[TBL] [Abstract][Full Text] [Related]
12. Proton magnetic resonance imaging and spectroscopic studies of the pathogenesis and treatment of juvenile dermatomyositis.
Slopis JM; Jackson EF; Narayana PA; Papasozomenos SC; Butler IJ
J Child Neurol; 1993 Jul; 8(3):242-9. PubMed ID: 8409266
[TBL] [Abstract][Full Text] [Related]
13. [Juvenile dermatomyositis].
Dressler F; Huppertz HI
Z Rheumatol; 2006 Nov; 65(7):587-90, 592-4. PubMed ID: 17051362
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis.
Park JH; Vital TL; Ryder NM; Hernanz-Schulman M; Partain CL; Price RR; Olsen NJ
Arthritis Rheum; 1994 May; 37(5):736-46. PubMed ID: 8185702
[TBL] [Abstract][Full Text] [Related]
15. Quantitative assessment of MRI T2 relaxation time of thigh muscles in juvenile dermatomyositis.
Maillard SM; Jones R; Owens C; Pilkington C; Woo P; Wedderburn LR; Murray KJ
Rheumatology (Oxford); 2004 May; 43(5):603-8. PubMed ID: 14983103
[TBL] [Abstract][Full Text] [Related]
16. Submaximal Exercise Capacity in Juvenile Dermatomyositis after Longterm Disease: The Contribution of Muscle, Lung, and Heart Involvement.
Berntsen KS; Tollisen A; Schwartz T; Kirkhus E; Aaløkken TM; Lund MB; Flatø B; Sjaastad I; Sanner H
J Rheumatol; 2017 Jun; 44(6):827-834. PubMed ID: 28365577
[TBL] [Abstract][Full Text] [Related]
17. Muscle MRI at the time of questionable disease flares in Juvenile Dermatomyositis (JDM).
Abdul-Aziz R; Yu CY; Adler B; Bout-Tabaku S; Lintner KE; Moore-Clingenpeel M; Spencer CH
Pediatr Rheumatol Online J; 2017 Apr; 15(1):25. PubMed ID: 28403889
[TBL] [Abstract][Full Text] [Related]
18. Use of P-31 magnetic resonance spectroscopy to detect metabolic abnormalities in muscles of patients with fibromyalgia.
Park JH; Phothimat P; Oates CT; Hernanz-Schulman M; Olsen NJ
Arthritis Rheum; 1998 Mar; 41(3):406-13. PubMed ID: 9506567
[TBL] [Abstract][Full Text] [Related]
19. Design of the muscles in motion study: a randomized controlled trial to evaluate the efficacy and feasibility of an individually tailored home-based exercise training program for children and adolescents with juvenile dermatomyositis.
Habers EA; van Brussel M; Langbroek-Amersfoort AC; van Royen-Kerkhof A; Takken T
BMC Musculoskelet Disord; 2012 Jun; 13():108. PubMed ID: 22721424
[TBL] [Abstract][Full Text] [Related]
20. Phosphorus 31 magnetic resonance spectroscopy for quantitative evaluation of therapeutic regimens in dermatomyositis.
King LE; Park JH; Adams LB; Olsen NJ
Arch Dermatol; 1995 May; 131(5):522-4. PubMed ID: 7741537
[No Abstract] [Full Text] [Related]
[Next] [New Search]
